{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:41:24Z","timestamp":1760834484413,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014114","name":"GW Pharmaceuticals, United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jocn.2020.05.030","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T11:23:14Z","timestamp":1589196194000},"page":"85-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The efficacy of cannabidiol on renal angiomyolipoma and subependymal giant cell tumor volume in tuberous sclerosis complex"],"prefix":"10.1016","volume":"77","author":[{"given":"James R.","family":"Barnett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reid A.","family":"Grinspoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Harisinghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2020.05.030_b0005","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000142039.14522.1A","article-title":"Subependymal giant cell tumors in tuberous sclerosis complex","volume":"63","author":"Goh","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2020.05.030_b0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.jocn.2020.05.030_b0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2014.10.028","article-title":"Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy","volume":"52","author":"Curatolo","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jocn.2020.05.030_b0020","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jocn.2020.05.030_b0025","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00381-011-1406-0","article-title":"The management of subependymal giant cell tumors in tuberous sclerosis: a clinician\u2019s perspective","volume":"27","author":"Moavero","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jocn.2020.05.030_b0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2020.05.030_b0035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4103\/0028-3886.190274","article-title":"Role of mTOR signaling pathway in the pathogenesis of subependymal giant cell astrocytoma \u2013 A study of 28 cases","volume":"64","author":"Kumari","year":"2016","journal-title":"Neurol India"},{"key":"10.1016\/j.jocn.2020.05.030_b0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/jdv.13356","article-title":"Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review","volume":"30","author":"Sadowski","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jocn.2020.05.030_b0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jamaneurol.2018.3550","article-title":"The US Food and Drug Administration\u2019s authorization of the first cannabis-derived pharmaceutical: are we out of the haze?","volume":"76","author":"Yang","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jocn.2020.05.030_b0050","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neuro.2015.08.007","article-title":"Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: possible role of the mTOR pathway and reduction in glutamate release","volume":"50","author":"Gobira","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jocn.2020.05.030_b0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","article-title":"Target regulation of PI3K\/Akt\/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis","volume":"116","author":"Giacoppo","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.jocn.2020.05.030_b0060","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR\/p70S6 kinase signaling pathway","volume":"36","author":"Renard","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.jocn.2020.05.030_b0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fphar.2017.00144","article-title":"Cannabidiol reduces leukemic cell size \u2013 but is it important?","volume":"8","author":"Kalenderoglou","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jocn.2020.05.030_b0070","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jocn.2020.05.030_b0075","doi-asserted-by":"crossref","unstructured":"Andersen PE, Thorlund MG, Wennevik GE, Pedersen RL, Lund L. Interventional treatment of renal angiomyolipoma: immediate results and clinical and radiological follow-up of 4.5\u00a0years. Acta Radiol Open 2015;4:2058460115592442. https:\/\/doi.org\/10.1177\/2058460115592442.","DOI":"10.1177\/2058460115592442"},{"key":"10.1016\/j.jocn.2020.05.030_b0080","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/2327-6924.12081","article-title":"Role of mTOR inhibition in the treatment of patients with renal angiomyolipomas","volume":"25","author":"Coombs","year":"2013","journal-title":"J Am Assoc Nurse Pract"},{"key":"10.1016\/j.jocn.2020.05.030_b0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10334-017-0614-3","article-title":"What are the true volumes of SEGA tumors? Reliability of planimetric and popular semi-automated image segmentation methods","volume":"30","author":"Stawiski","year":"2017","journal-title":"MAGMA"},{"key":"10.1016\/j.jocn.2020.05.030_b0090","doi-asserted-by":"crossref","unstructured":"Roth J, Roach ES, Bartels U, Jozwiak S, Koenig MK, Weiner HL, et al. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 2013;49:439\u201344. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2013.08.017.","DOI":"10.1016\/j.pediatrneurol.2013.08.017"},{"key":"10.1016\/j.jocn.2020.05.030_b0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/adc.2009.159210","article-title":"Sirolimus and tuberous sclerosis-associated renal angiomyolipomas","volume":"95","author":"Krischock","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jocn.2020.05.030_b0100","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2174\/157015912804499537","article-title":"mTOR inhibitors in tuberous sclerosis complex","volume":"10","author":"Curatolo","year":"2012","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jocn.2020.05.030_b0105","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/epi.13499","article-title":"Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex","volume":"57","author":"Hess","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2020.05.030_b0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1515\/revneuro-2017-0027","article-title":"The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review","volume":"29","author":"Chan","year":"2018","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.jocn.2020.05.030_b0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2016.01.048","article-title":"Natural History of Renal Angiomyolipoma (AML): most patients with large AMLs >4\u00a0cm can be offered active surveillance as an initial management strategy","volume":"70","author":"Bhatt","year":"2016","journal-title":"Eur Urol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820305658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586820305658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:23:20Z","timestamp":1760822600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586820305658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":23,"alternative-id":["S0967586820305658"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2020.05.030","relation":{},"ISSN":["0967-5868"],"issn-type":[{"type":"print","value":"0967-5868"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy of cannabidiol on renal angiomyolipoma and subependymal giant cell tumor volume in tuberous sclerosis complex","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2020.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}